Perspective
Published on 03 Jun 2024
The continuing value of mesalazine as first-line therapy for patients with moderately active ulcerative colitis
in Therapy in Gastroenterology
- 8,157 views
- 4 citations
Perspective
Published on 03 Jun 2024
in Therapy in Gastroenterology
Original Research
Published on 28 May 2024
in Therapy in Gastroenterology
Original Research
Published on 24 May 2024
in Hepatology
Mini Review
Published on 22 May 2024
in Endoscopy
Mini Review
Published on 15 May 2024
in Hepatology
Case Report
Published on 08 May 2024
in Endoscopy
Editorial
Published on 07 May 2024
in Hepatology
Review
Published on 02 May 2024
in Therapy in Gastroenterology
Study Protocol
Published on 02 Apr 2024
in Endoscopy
Brief Research Report
Published on 22 Mar 2024
in Gastroenterology and Cancer
Original Research
Published on 18 Mar 2024
in Therapy in Gastroenterology
Review
Published on 04 Mar 2024
in Gastrointestinal Infection
Editorial
Published on 25 Jan 2024
in Gastroenterology and Cancer
Original Research
Published on 24 Jan 2024
in Therapy in Gastroenterology
Systematic Review
Published on 24 Jan 2024
in Hepatology
Brief Research Report
Published on 16 Jan 2024
in Gastroenterology and Cancer
Editorial
Published on 11 Jan 2024
in Gastroenterology and Cancer
Original Research
Published on 04 Jan 2024
in Therapy in Gastroenterology
Original Research
Published on 04 Jan 2024
in Hepatology
Review
Published on 04 Dec 2023
in Hepatology
Perspective
Published on 20 Nov 2023
in Endoscopy
Mini Review
Published on 17 Nov 2023
in Endoscopy
Systematic Review
Published on 17 Nov 2023
in Hepatology
Editorial
Published on 13 Nov 2023
in Gastrointestinal Infection